Bayesian Capital Management’s Janux Therapeutics JANX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-8,300	Closed	-$444K	–	783
2024 Q4	$444K	Buy	+8,300	New	+$444K	0.05%	392
2024 Q3	–	Sell	-5,600	Closed	-$235K	–	868
2024 Q2	$235K	Buy	+5,600	New	+$235K	0.03%	565